Skip to main content

Table 2 Pathogenic variants detected by BRCA Panel

From: Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study

Gene

Transcript

Locus

Exon

Intron

Frequency

Quality

Coding

Protein

Function

dbSNP

Clinical Significance

Enigma Classification

No. of Patients

BRCA1

NM_007294.3

chr17:41245972

10

47.1

1980.35

c.1576C > T

p.Gln526Ter

Nonsense

rs80356984

Pathogenic

C 5

1

BRCA1

NM_007294.3

chr17:41234451

12

47

410.40

c.4327C > T

p.Arg1443Ter

Nonsense

rs41293455

Pathogenic

C 5

1

BRCA1

NM_007294.3

chr17:41215920

17

50

533.95

c.5123C > A

p.Ala1708Glu

Missense

rs28897696

Pathogenic

C 5

1

BRCA1

NM_007294.3

chr17:41201198

21

43.2

387.66

c.5346G > A

p.Trp1782Ter

Nonsense

rs80357284

Pathogenic

C 5

1

BRCA1

NM_007294.3

chr17:41246724

9

43.4

242.36

c.682_683insAGCCATGTGG

p.Gly228Glufs*15

Frameshift

Pathogenic

C 5

1

BRCA1

NM_007294.3

chr17:41197819–41203079

21–22

**c.5278-?_5406 +?dup

p.?

Duplication

Pathogenic

C5

1

BRCA1

NM_007294.3

chr17:41215390–41222944

16–17

**c.4676-?_5074 +?del

p.?

Deletion

Pathogenic

C5

3

BRCA1

NM_007294.3

chr17:41228631–41249260

9–12

** c.548-?_4185 +?del

p.?

Deletion

Pathogenic

C5

3

BRCA1

NM_007294.3

chr17:41267796–41278345

P-2

**c.-716-?_80 +?del

p.?

Deletion

Pathogenic

C5

1

BRCA2

NM_000059.3

chr13:32945092

19

38.5

1538.41

c.8488-1G > A

p.?

Splice Acceptor Site

rs397507404

Pathogenic

C5

1

BRCA2

NM_000059.3

chr13:32954050

23

81.8

450.72

c.9117G > A

p.Pro3039=

synonymous

rs28897756

Pathogenic

C5

1

BRCA2

NM_000059.3

chr13:32944584

12

49.6

503.98

*c.8377G > A

p.Gly2793Arg

Missense

rs80359082

Pathogenic

C5

1

  1. Abbreviations: dbSNP Single Nucleotide Polymorphisms database, ENIGMA Evidence-based Network for the Interpretation of Germline Mutant Alleles, C5 Class 5 – (there is significant evidence to suggest that this variant is a dominant high-risk pathogenic variant
  2. *Pathogenic variants on control group
  3. **Detected by MLPA method